N17600/S047: Avitene Microfibrillar Collagen Hemostat (MCH) Flour; Avitene Microfibrillar Collagen Hemostat (MCH) UltraFoam; Avitene
FDA’s recorded scope: updated water system equipment for the Woburn, MA manufacturing site
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 2 FDA records to the applicant name Davol Inc., Sub. C. R. Bard, Inc.. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from May 11, 2026 to Jul 15, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code LMF appears in 2 of the 2 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 100 Crossings Blvd., Warwick, RI, 02886. Recorded on N17600/S047, decision dated Jul 15, 2026.
FDA’s recorded scope: updated water system equipment for the Woburn, MA manufacturing site
FDA’s recorded scope: a new vacuum oven for the Avitene Flowable product at the Woburn, MA manufacturing facility
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.